Patent details

EP2305804 Title: MonoPEGylated human growth hormone

Basic Information

Publication number:
EP2305804
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP100124866
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
MonoPEGylated human growth hormone
French Title of Invention:
Hormone de croissance humaine monoPEGylée
German Title of Invention:
MonoPEGyliertes menschliches Wachstumshormon
SPC Number:

Dates

Filing date:
14/01/2000
Grant date:
06/05/2015
EP Publication Date:
06/05/2015
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/04/2011
EP B1 Publication Date:
06/05/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
14/01/2016
Expiration date:
14/01/2020
Renunciation date:
Revocation date:
18/09/2017
Annulment date:

Owner

From:
14/01/2000
 
 

Name:
Bolder Biotechnology Inc.
Address:
678 West Willow Street, Louisville, CO 80027, United States (US)

Inventor

1

Name:
Rosendahl Mary S.
Address:
United States (US)

2

Name:
Cox George N.
Address:
United States (US)

3

Name:
Doherty Daniel H.
Address:
United States (US)

Priority

Priority Number:
116041 P
Priority Date:
14/01/1999
Priority Country:
United States (US)

Classification

Main IPC Class:
C12N 15/00;

Publication

European Patent Bulletin

Issue number:
201810
Publication date:
07/03/2018
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages